阿根廷风湿病学会2025年类风湿关节炎治疗建议更新(第一部分)
阿根廷风湿病学会工作组通过系统文献综述与GRADE方法制定21条类风湿关节炎治疗建议,涵盖甲氨蝶呤皮下与口服、csDMARD初治与应答不足、b/tsDMARD循环与转换、单药治疗、持续缓解减量及合并间质性肺病或类风湿血管炎的管理。多数证据等级与共识程度为中等,共识阈值为至少70%同意。
要点
- 建议涵盖甲氨蝶呤皮下与口服的选择及csDMARD初治与应答不足的策略。
- 对b/tsDMARD应答不足者提供循环与转换的推荐。
- 合并间质性肺病或类风湿血管炎患者有专门管理建议。
核心结论
- 该建议旨在为风湿科医生提供实用工具,以做出最适合患者的治疗决策。
研究设计与样本
- 系统文献综述检索Medline(PubMed)、LILACS和Cochrane Library数据库,并检索灰色文献。
- 采用GRADE方法评价证据,匿名线上投票,推荐需至少70%同意达成共识。
主要发现
- 共制定21条推荐,涉及地中海饮食、甲氨蝶呤皮下与口服比较及不同临床场景的治疗策略。
- 治疗场景包括csDMARD初治、csDMARD应答不足、b/tsDMARD应答不足(循环与转换)、单药治疗、持续缓解减量及合并间质性肺病或类风湿血管炎的管理。
- 多数情况下证据等级和共识程度为中等。
关键数值与推荐
- 推荐达成共识需至少70%同意。
临床怎么用
- 可用于指导类风湿关节炎不同治疗阶段的选择,包括甲氨蝶呤给药途径及生物/靶向合成DMARD的循环与转换决策。
- 对合并间质性肺病或类风湿血管炎的患者提供专门管理参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
J Clin Rheumatol. 2026 Jul 27. doi: 10.1097/RHU.0000000000002391. Online ahead of print. ABSTRACT BACKGROUND: Rheumatoid arthritis (RA) is a severe, systemic chronic rheumatic disease, and it is important for each country and/or region to develop management recommendations adapted to its needs and resources. OBJECTIVES: To update the Argentine treatment recommendations for the management of patients with RA. METHODS: The working group comprised a principal investigator, 8 methodologists and 23 expert rheumatologists. Seventy-one PICO questions were developed. A systematic literature review (SLR) was conducted using the Medline (PubMed), LILACS, and Cochrane Library databases. Grey literature was also searched. The evidence was appraised using the GRADE methodology. Voting was anonymous and conducted virtually, and recommendations required at least 70% agreement to achieve consensus. RESULTS: A total of 21 recommendations were developed, addressing Mediterranean diet, subcutaneous versus oral methotrexate, and therapeutic strategies across different clinical scenarios, including: csDMARD naive, inadequate response (IR) to csDMARD, IR to b/tsDMARD (cycling versus swapping), monotherapy, tapering in patients with sustained remission, and management of patients with concomitant interstitial lung disease or rheumatoid vasculitis. In most cases, the levels of evidence and degrees of agreement were moderate. CONCLUSIONS: These recommendations are intended to be a practical tool to assist rheumatologists in making the most appropriate treatment decisions for their patients. PMID: 42507767 | DOI: 10.1097/RHU.0000000000002391
引用
- 指南共识 · 间质性肺病:Recommendations of the Argentine Society of Rheumatology for the Treatment of Patients With Rheumatoid Arthritis: 2025 Update Part I
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。